Abstract:Background aims: In this article we aimed to provide an expert synthesis of the current status of Schwann cell (SC)therapeutics and potential steps to increase their clinical utility. Methods: We provide an expert synthesis based on preclinical, clinical and manufacturing experience. Results: Schwann cells (SCs) are essential for peripheral nerve regeneration and are of interest in supporting axonal repair after spinal cord injury (SCI). SCs can be isolated and cultivated in tissue culture from adult nerve biopsies or generated from precursors and neural progenitors using specific differentiation protocols leading to expanded quantities. In culture, they undergo dedifferentiation to a state similar to "repair" SCs. The known repertoire of SC functions is increasing beyond axon maintenance, myelination, and axonal regeneration to include immunologic regulation and the release of potentially therapeutic extracellular vesicles. Recently, autologous human SC cultures purified under cGMP conditions have been tested in both nerve repair and subacute and chronic SCI clinical trials. Although the effects of SCs to support nerve regeneration are indisputable, their efficacy for clinical SCI has been limited according to the outcomes examined. Conclusions: This review discusses the current limitations of transplanted SCs within the damaged spinal cord environment. Limitations include limited post-transplant cell survival, the inability of SCs to migrate within astrocytic parenchyma, and restricted axonal regeneration out of SC-rich graft regions. We describe steps to amplify the survival and integration of transplanted SCs and to expand the repertoire of uses of SCs, including SC-derived extracellular vesicles. The relative merits of transplanting autologous versus allogeneic SCs and the role that endogenous SCs play in spinal cord repair are described. Finally, we briefly describe the issues requiring solutions to scale up SC manufacturing for commercial use.

Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration

Engineered Schwann Cell-Based Therapies for Injury Peripheral Nerve Reconstruction

Improved Axonal Regeneration of Transected Spinal Cord Mediated by Multichannel Collagen Conduits Functionalized with Neurotrophin-3 Gene

Schwann Cell-Like Cells Derived from Human Amniotic Mesenchymal Stem Cells Promote Peripheral Nerve Regeneration Through a MicroRNA-214/c-Jun Pathway

Challenges in advancing Schwann cell transplantation for spinal cord injury repair

Biomaterial-Based Schwann Cell Transplantation and Schwann Cell-Derived Biomaterials for Nerve Regeneration

Peripheral Nerve Regeneration through Hydrogel-Enriched Chitosan Conduits Containing Engineered Schwann Cells for Drug Delivery

Nanoparticles for neurotrophic factor delivery in nerve guidance conduits for peripheral nerve repair.

Nerve Conduit Filled with GDNF Gene-Modified Schwann Cells Enhances Regeneration of the Peripheral Nerve

Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy

Localised Non-Viral Delivery of Nucleic Acids for Nerve Regeneration in Injured Nervous Systems

Schwann cell delivery via a novel 3D collagen matrix conduit improves outcomes in critical length nerve gap repairs.

Peripheral Nerve Regeneration-Adipose-Tissue-Derived Stem Cells Differentiated by a Three-Step Protocol Promote Neurite Elongation via NGF Secretion

Schwann Cell-Like Cells: Origin and Usability for Repair and Regeneration of the Peripheral and Central Nervous System

Schwann cell autotransplantation for the treatment of peripheral nerve injury

Therapeutic strategies for peripheral nerve injury: decellularized nerve conduits and Schwann cell transplantation

Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration.

Neurotrophic Factor Gene Delivery Supports Axonal Regeneration after Injury

Nanofibrous Nerve Conduits with Nerve Growth Factors and Bone Marrow Stromal Cells Pre-Cultured in Bioreactors for Peripheral Nerve Regeneration

Augmenting Peripheral Nerve Regeneration with Adipose-Derived Stem Cells

Schwann Cell-Seeded Scaffold with Longitudinally Oriented Micro-Channels for Reconstruction of Sciatic Nerve in Rats